Effects of Cycling Workstation on Cardiometabolic Health for Workers With an Office-sitting Desk (REMOVE)
NCT ID: NCT04153214
Last Updated: 2020-01-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
75 participants
INTERVENTIONAL
2020-01-06
2022-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective of this project is to study the effects of the use of a cycling workstation for 60 minutes per day (30 minutes twice a day) for 3 months among professionals with an office-sitting desk on overall quantity of physical activity time (work and non-work) and sedentary time.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Energy Profile and Low Intensity Activity (PROFILE)
NCT04864028
Use of a DeskCycle to Reduce Sedentary Behavior During the Workday
NCT05412797
Effectivness of Active Office Intervention
NCT03649893
Pedal@Work: A Worksite Wellness Program
NCT01371084
Reduce Sedentary Behavior at Work
NCT03816150
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After the inclusion of subject and their agreements to participate to the study, they will know in which group they are :
* Group who performs 30minutes twice a working day from day 1 to day 180 (interventional)
* Group who performs 30minutes twice a working day from day 90 to day 180 (control)
They will have evaluation at three different times : T0 (Day 1), T1 (Day 90), T2 (Day 180). The evaluation will evaluate :
* overall quantity and quality of physical activity time (work and non-work) and sedentary time
* Body composition
* Biological parameters
* Physical fitness
* Psychological parameters At the end of the protocol, there will be an assessment of the obstacles or motivations to this program.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cycling workstation
Participants will have a portable pedal machine under their desk and will use it 60minutes per day (30minutes in the morning and 30minutes in the afternoon) during 6 months
cycling
Participants will have a portable pedal machine under their desk and will use it 60minutes per day
control
Daily activities unchanged during 3 months. Then they will have a portable pedal machine under their desk and will use it 60minutes per day (30minutes in the morning and 30minutes in the afternoon) during 3 months.
cycling
Participants will have a portable pedal machine under their desk and will use it 60minutes per day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cycling
Participants will have a portable pedal machine under their desk and will use it 60minutes per day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body mass index \> 18,5 kg/m2 and ≤ 35 kg/m2
* More than 0.8 full time equivalent hours (FTE) with 75% of this time in a sitting position
* Able to provide informed consent to research participation
* Registered in the French social security system
Exclusion Criteria
* Subject using a sit-to-stand office desk or a swiss ball
* Sports activity \> 2.5 hours/week
* Contact jobs (face-to-face with people)
* Pregnant or breastfeeding women
* Medical or surgical history determined by principal investigator to be not compatible with the study
* Subject with cardiorespiratory and/or osteo-articular disorders limiting their ability to perform physical tests or the use of active offices
* Subject with type 1 or type 2 diabetes treated with insulin
* Subject with progressive cardiovascular or neoplastic disease.
* Subject with a major infection within 3 months of inclusion.
* Subject with known neuromuscular pathology: myopathy, myasthenia, rhabdomyolysis, paraplegia, hemiplegia
* Subject with chronic or acute inflammatory pathology 3 months prior to inclusion
* Subject treated by beta-blocker
* Subject diagnosed and/or treated for schizophrenia, bipolar disorders, major depression
* Subject treated, or having stopped treatment for less than 3 months prior to inclusion, by corticosteroids, immunosuppressant, anabolic, growth hormone.
* Subject with unstable psychiatric condition
* Significant alcohol consumption (\> 2-3 drinks per day depending on gender) or presence of substance abuse.
* Unable to walk or pedal 45 minutes in a row
* Subject who is excluded from another study or who received more than €4,500 in the year following his participation in clinical studies
* Subject deprived of their liberty by judicial or administrative decision
* Refusal to sign written consent to participate
* Subject participating in another study
18 Years
61 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laboratoire AME2P - Unversité Clermont Auvergne
UNKNOWN
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martine Duclos
Role: PRINCIPAL_INVESTIGATOR
CHU de Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Clermont-Ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Nasir H, Dutheil F, Ramos I, Guirado T, de Saint-Vincent S, Thivel D, Metz L, Duclos M. Effects of portable pedal machines at work on lipoprotein subfraction profile in sedentary workers - the REMOVE study. Lipids Health Dis. 2024 Apr 14;23(1):105. doi: 10.1186/s12944-024-02098-w.
Guirado T, Metz L, Pereira B, Brun C, Birat A, Boscaro A, Bergouignan A, Thivel D, Duclos M. A 12-Week Cycling Workstation Intervention Improves Cardiometabolic Risk Factors in Healthy Inactive Office Workers. J Occup Environ Med. 2022 Aug 1;64(8):e467-e474. doi: 10.1097/JOM.0000000000002583. Epub 2022 Jun 11.
Guirado T, Metz L, Pereira B, Bergouignan A, Thivel D, Duclos M. Effects of cycling workstation to get tertiary employee moving on their overall health: study protocol for a REMOVE trial. Trials. 2021 May 22;22(1):359. doi: 10.1186/s13063-021-05317-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A04449-48
Identifier Type: OTHER
Identifier Source: secondary_id
RBHP 2019 DUCLOS 2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.